Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Seres Therapeutics Reports Initiation Of Phase 1b Trial Of SER-301 For Treatment Of Ulcerative Colitis


Benzinga | Nov 6, 2020 07:05AM EST

Seres Therapeutics Reports Initiation Of Phase 1b Trial Of SER-301 For Treatment Of Ulcerative Colitis






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC